The appeal of an oral testosterone offer is easy to understand: a medicine taken by mouth may feel more familiar than learning an injection routine. With Maximus, the first question is what medicine that offer describes. The company identifies it as compounded native testosterone, not an approved testosterone undecanoate brand.
We examined the public Maximus treatment and oral-product pages on September 23, 2026. This review does not report a patient experience or independently confirmed results. It looks at what the company states, what those statements establish, and what should still be explained by the prescribing clinician and dispensing pharmacist.
KEEP IN MIND
A few things to remember.
- The advertised oral preparation is compounded native testosterone.
- Separate the temporary discount from the continuing commitment.
- Ask what evidence supports product-specific safety and fertility statements.
Read the product description before the headline benefits
Compounded native testosterone and Kyzatrex are different products. Kyzatrex contains testosterone undecanoate and has FDA-approved labeling. Maximus’s oral preparation does not acquire that approval simply because it is also a testosterone medicine taken by mouth. Instructions and evidence need to follow the particular product being prescribed.
Ask why the clinician proposes a compounded preparation for your needs, which alternatives were considered, and which pharmacy would make and dispense it. FDA does not approve compounded medicines. Our oral-label reading guide walks through the identity questions. It is reasonable to want a plain explanation of what is in the capsule before considering a claim about how it might help.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · FDA: understanding the risks of compounded drugs · DailyMed: Kyzatrex oral testosterone undecanoate prescribing information
The discount and the ongoing rate are separate numbers
The current oral page shows $249.99 monthly for a one-month option, $199.99 monthly for three months, and $149.99 monthly for six months. It also advertises a limited six-month offer with a $74.99 first month followed by the $149.99 monthly rate. The page notes that price can depend on dose, state, and plan.
Write down the amount taken today, the next charge, and the total obligation. A monthly figure attached to a longer plan does not by itself answer whether the full term is committed or how cancellation works. Ask what happens to charges after a clinical change. Do not use an introductory rate as if it continued for the entire year.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements
Existing results still need a clinician’s interpretation
Maximus describes required testing before and during care. Qualifying laboratory reports from the preceding six months may be submitted for review, with the necessary markers included. Acceptance is conditional; an upload does not guarantee that the assessment can proceed without a repeat sample or another test.
Provide the entire report and explain any medicine used when it was collected. Ask when follow-up testing should occur and how results are discussed. Our laboratory-plan article separates the blood draw from the clinical decision that follows. The useful question is not only whether a report is recent, but whether it answers the questions relevant to your current health and treatment.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · Endocrine Society: testosterone therapy clinical guidance
Be precise about what a study measured
The oral page refers to company research and makes claims related to laboratory outcomes and fertility. We have not independently verified these claims. Changes in blood hormone levels do not, on their own, demonstrate preserved sperm production or establish the likelihood of a future pregnancy.
Tell the clinician about current or possible future fertility goals before starting testosterone. AUA/ASRM guidance cautions against testosterone monotherapy for men interested in fertility. Our TRT and fertility questions explains why this deserves its own discussion. Ask for evidence about the outcome that matters to you, rather than treating a reassuring marketing phrase as a guarantee about your personal situation.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · AUA/ASRM: male infertility guideline, amended 2024
Take the final instructions from the care team
The public page uses inconsistent wording about pill routines. We do not resolve that into a suggested dose or schedule. Your prescription label, pharmacist, and prescriber should give one clear set of instructions. Ask them to reconcile any difference before taking the medicine, including timing around food or a blood draw where relevant.
A route that avoids injections still needs a monitoring plan. Discuss blood pressure, blood counts, new symptoms, and other individualized concerns. FDA’s testosterone labeling update did not remove all safety questions. Also ask how to reach a clinician between appointments and how a reported problem is assessed before another medication shipment is authorized.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · FDA: 2025 testosterone labeling and blood pressure changes
Compare the offer with the right alternative
Maximus’s broader treatment menu includes options beyond the oral preparation. Each needs its own product description and quote. A topical or injectable plan should not be assigned the oral page’s price, and enclomiphene should not be treated as simply another form of replacement testosterone.
For a concrete comparison, read Maximus versus PeterMD, which separates the compounded oral offer from PeterMD’s advertised injection plan. If you are still investigating oral care, the oral-question shortlist helps organize the next conversation. The right starting point is a diagnosis and understandable prescription, followed by a financial commitment you can evaluate with the full terms in hand.
Sources: Maximus: testosterone treatment options · PeterMD: injectable testosterone plans, payment terms, and state exclusions
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 23, 2026; prices and availability can change.
- Maximus: compounded oral testosterone, plan prices, and laboratory requirements
- FDA: understanding the risks of compounded drugs
- DailyMed: Kyzatrex oral testosterone undecanoate prescribing information
- Endocrine Society: testosterone therapy clinical guidance
- AUA/ASRM: male infertility guideline, amended 2024
- FDA: 2025 testosterone labeling and blood pressure changes
- Maximus: testosterone treatment options
- PeterMD: injectable testosterone plans, payment terms, and state exclusions
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.